A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 16 Sep 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 Oct 2011 Results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
22 Oct 2011 Results will be presented at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA), according to a Romark Laboratories media release. Results were also reported in the media release.
22 Oct 2011 Primary endpoint 'Time-to-resolution-of-symptoms' has been met, according to a Romark Laboratories media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com